ECV in the right ventricle decreases after CTEPH treatment (26.1% vs. 29.1%) and correlates with pulmonary artery pressure (p < 0.01) and BNP (p < 0.05). This evidence concerns the gene NPPB and chronic thromboembolic pulmonary hypertension.